Practice Management

Newsweek Recognizes Recuro Health As One Of The World’s Best Digital Health Companies in 2024

Retrieved on: 
Tuesday, April 30, 2024
Software, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Health, Data Management, Health Technology, Technology, Statista, Primary care, Head, Holon, Chronic condition, Diabetes, Digital, Digital health, Patient, Multimedia, Mental health, Hospital

Recuro Health , a leading digital health company specializing in virtual care services including primary care, urgent care, behavioral health, and supplemental benefits, has been recognized and featured in Newsweek's prestigious " World's Best Digital Health Companies 2024 " list.

Key Points: 
  • Recuro Health , a leading digital health company specializing in virtual care services including primary care, urgent care, behavioral health, and supplemental benefits, has been recognized and featured in Newsweek's prestigious " World's Best Digital Health Companies 2024 " list.
  • View the full release here: https://www.businesswire.com/news/home/20240430587361/en/
    Newsweek Recognizes Recuro Health As One Of The World’s Best Digital Health Companies in 2024 (Graphic: Business Wire)
    Digital health has become an integral part of the global healthcare landscape, revolutionizing the way patients access medical services and manage their health.
  • Recuro Health's inclusion in this esteemed list highlights its commitment to providing exceptional digital health solutions that make advanced healthcare accessible.
  • "We are honored to be recognized among the world's top digital health companies by Newsweek," said Phil Fasano, CEO and Chairman of the Board for Recuro Health.

Autonomize AI Strengthens Leadership Team with Key Appointments

Retrieved on: 
Tuesday, April 30, 2024
Technology, Health Technology, Professional Services, Software, Practice Management, Health, Data Analytics, Data Management, Artificial Intelligence, Information technology, Acceleration, Wells Fargo, Hospital, Artificial intelligence in healthcare, LLM, London Business School, Health care, Business development, Doctor of Philosophy, CVS Health, Artificial intelligence, J. P. Morgan, Lafayette College, MBA, Growth

Autonomize AI, a pioneer in AI-driven healthcare solutions, announced two key appointments to its leadership team: Jennifer Kloke, PhD , as Vice President of Artificial Intelligence (AI), and Jeffrey Eyestone as Vice President of Business Development.

Key Points: 
  • Autonomize AI, a pioneer in AI-driven healthcare solutions, announced two key appointments to its leadership team: Jennifer Kloke, PhD , as Vice President of Artificial Intelligence (AI), and Jeffrey Eyestone as Vice President of Business Development.
  • Jennifer’s expertise in integrating AI with user-centric product design is key in driving AI adoption in healthcare for Autonomize.
  • Ganesh Padmanabhan , CEO of Autonomize AI, expressed his enthusiasm about the new additions: “We are thrilled to welcome Jennifer and Jeffrey to our team.
  • Their vast experience and innovative vision will be crucial as we continue to expand the possibilities of AI in healthcare.”
    These appointments come at a pivotal time for Autonomize AI, as it gears up for significant growth and innovation, reinforcing its position as a leader in healthcare AI.

Healthcare Organizations Lose 20% of their Sensitive Data in Every Ransomware Attack, Reports Rubrik Zero Labs

Retrieved on: 
Tuesday, April 30, 2024
Technology, Hospitals, Security, Health Technology, Software, Practice Management, Networks, Health, Data Management, Cloud, Human Impact, Architecture, Risk, PII, Research, Software as a service, Cybercrime, PHI, VPS, Organization, Cryptocurrency

New research by Rubrik Zero Labs reveals that ransomware attacks produce larger impacts against these healthcare targets.

Key Points: 
  • New research by Rubrik Zero Labs reveals that ransomware attacks produce larger impacts against these healthcare targets.
  • In fact, the report estimates that one fifth of all sensitive data belonging to healthcare organizations is impacted in each ransomware attack.
  • A typical healthcare organization has more than 42 million sensitive data records — 50% more sensitive data than the global average of 28 million.
  • Ransomware attacks against observed healthcare organizations have an estimated impact of almost five times more sensitive data than the global average.

Leading Radiation Oncologist Dr. Steven E. Finkelstein Joins Associated Medical Professionals of NY, an Affiliate of U.S. Urology Partners

Retrieved on: 
Tuesday, April 30, 2024
Medical Supplies, Biotechnology, Practice Management, Managed Care, Health, General Health, Radiology, Oncology, Medical Devices, Hospitals, Clinical Trials, Corporation, Micron Technology, University, Bangladesh Technical Education Board, Kidney, Hospital, Clinical research, Breast, National Cancer Institute, NMS, Literature, CARE, Prostate cancer, Radiation therapy, Patient, National Institutes of Health, Medicine, Physician, Lung, Radiation, Cancer, Medical imaging

Associated Medical Professionals of NY spans 18 locations in Central New York, including nine offices and nine hospitals.

Key Points: 
  • Associated Medical Professionals of NY spans 18 locations in Central New York, including nine offices and nine hospitals.
  • Radiation Oncology is the region’s leading provider of comprehensive cancer care services, providing the most advanced, effective treatments available for urological and other types of cancers.
  • Steven Finkelstein’s extensive experience in radiation oncology care and his leadership in the medical field will be a tremendous asset to U.S. Urology Partners, Associated Medical Professionals of NY and most importantly to individuals receiving cancer care in the Central New York region.
  • I am excited to join the team of Associated Medical Professionals of NY and look forward to helping patients in the community.”

Shore Capital Partners Announces Partnership with PRO-spectus

Retrieved on: 
Tuesday, April 30, 2024
Medical Devices, Finance, Consulting, Professional Services, Practice Management, Other Health, Biotechnology, Pharmaceutical, Health, Other Professional Services, Investment, Policy, Partnership, Business, Growth, SVP, Patient, Multimedia

Shore Capital Partners (“Shore” or “Shore Capital”), is pleased to announce it has completed a partnership with PRO-spectus (“the Company”), a provider of market access consulting and patient services headquartered in Huntington Beach, California.

Key Points: 
  • Shore Capital Partners (“Shore” or “Shore Capital”), is pleased to announce it has completed a partnership with PRO-spectus (“the Company”), a provider of market access consulting and patient services headquartered in Huntington Beach, California.
  • View the full release here: https://www.businesswire.com/news/home/20240430291874/en/
    Founded in 2008, PRO-spectus helps biopharmaceutical companies, medical device manufacturers, and diagnostic firms overcome barriers that stand between products and patients.
  • “We couldn’t be more excited about our partnership with Charmie and the PRO-spectus team.
  • Through our partnership, we are prepared to support PRO-spectus in reaching our shared objectives for long-term growth,” said Ryan Kelley, a Founding Partner of Shore and Chairman of PRO-spectus.

NeoGenomics Reports First Quarter 2024 Results

Retrieved on: 
Tuesday, April 30, 2024
Other Health, Pharmaceutical, Oncology, Hospitals, Genetics, Health Technology, Clinical Trials, Science, Biotechnology, Practice Management, Other Science, Health, NEO, NGS

NeoGenomics, Inc. (NASDAQ: NEO) (the “Company”), a leading provider of oncology testing and global contract research services, today announced its first-quarter results for the period ended March 31, 2024.

Key Points: 
  • NeoGenomics, Inc. (NASDAQ: NEO) (the “Company”), a leading provider of oncology testing and global contract research services, today announced its first-quarter results for the period ended March 31, 2024.
  • Consolidated gross profit for the first quarter of 2024 was $65.5 million, an increase of 19.4% compared to the first quarter of 2023.
  • Operating expenses for the first quarter of 2024 were $96 million, an increase of $6 million, or 6.8%, compared to the first quarter of 2023.
  • Net loss for the quarter was $27 million compared to net loss of $31 million for the first quarter of 2023.

Hospice of the Chesapeake Selects Netsmart myUnity® to Propel Organizational Growth and Advance Value-Based Care Initiatives

Retrieved on: 
Tuesday, April 30, 2024
Technology, Hospitals, Health Technology, Software, Practice Management, Other Health, Managed Care, Health, General Health, Medicine, Hospice, SVP, EHR, Patient, Palliative care, ONC, Nursing

This move underscores Hospice of the Chesapeake's commitment to enhancing patient care, supporting organizational growth and embracing value-based care models.

Key Points: 
  • This move underscores Hospice of the Chesapeake's commitment to enhancing patient care, supporting organizational growth and embracing value-based care models.
  • With myUnity, Netsmart can further support Hospice of the Chesapeake’s growth strategy through enhanced capabilities to drive efficiencies and optimize care delivery.
  • Post-implementation, clinical staff at Hospice of the Chesapeake have achieved transformative milestones, including streamlined care processes and enhanced patient experience.
  • Annually serving over 4,000 individuals, Hospice of Chesapeake stands at the forefront of hospice care delivery in the country.

Tenet Reports First Quarter 2024 Results Well in Excess of Guidance; Raises 2024 Financial Outlook

Retrieved on: 
Tuesday, April 30, 2024
General Health, Surgery, Hospitals, Health, Practice Management, Sale, Central Time, Hospital, Security (finance), Webcast, Particular, Ambulatory, NCI, GAAP

Tenet management will discuss the Company’s first quarter 2024 results in a webcast scheduled for 10:00 a.m. Eastern Time (9:00 a.m. Central Time) on April 30, 2024.

Key Points: 
  • Tenet management will discuss the Company’s first quarter 2024 results in a webcast scheduled for 10:00 a.m. Eastern Time (9:00 a.m. Central Time) on April 30, 2024.
  • This release contains “forward-looking statements” - that is, statements that relate to future, not past, events.
  • Same-facility system-wide revenues and statistical information include the results of the facilities in which the Ambulatory segment has an investment that are not consolidated by Tenet.
  • To help analyze the segment’s results of operations, management uses system-wide measures, which include revenues and cases of both consolidated and unconsolidated facilities.

GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions

Retrieved on: 
Monday, April 29, 2024
FDA, Health Technology, Data Management, Other Health, Technology, Practice Management, Pharmaceutical, Managed Care, General Health, Medical Devices, Hospitals, Other Technology, Biotechnology, Software, Nursing, Health, EWS, Mortality, GE HealthCare, Hospital, EMR, Health care, Vital signs, Respiratory rate, Workflow, Patient, Multimedia

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    Building on GE HealthCare’s family of Portrait monitoring solutions, Portrait VSM can connect with the latest iteration of the Portrait Mobile wireless and wearable continuous monitoring solution to seamlessly integrate patient data in one unified workflow, while ensuring patient mobility.
  • “We remain focused on tackling healthcare’s biggest challenges and driving further efficiencies for care teams through new patient monitoring technology.
  • Built on a well-established history of clinical advancements, GE HealthCare’s FlexAcuity monitoring solutions are engineered to adapt to rapidly changing patient needs.
  • For more information on Portrait VSM and GE HealthCare’s family of Portrait monitoring solutions, please visit: https://www.gehealthcare.com/products/patient-monitoring/portrait-vsm .

Medifast Announces First Quarter 2024 Financial Results

Retrieved on: 
Monday, April 29, 2024
Practice Management, Managed Care, Health, Hospitals, Health Technology, Health Insurance, Fitness & Nutrition, Other Health, Internet, Coach, Research, BCG, Future, OPTA, Pressure, Acquisition, EPS, Telephone, Growth, Music

Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA® , today reported results for the first quarter ended March 31, 2024.

Key Points: 
  • Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA® , today reported results for the first quarter ended March 31, 2024.
  • The total number of active earning OPTAVIA Coaches decreased 35.6% to 37,800 compared to 58,700 for the first quarter of 2023.
  • The effective tax rate was 28.2% for the first quarter of 2024 compared to 25.1% in the prior-year period.
  • The company expects second quarter 2024 revenue to be in the range of $150 million to $170 million and second quarter 2024 diluted EPS to be in the range of $0.05 to $0.40.